loading
Precedente Chiudi:
$12.20
Aprire:
$12.28
Volume 24 ore:
240.39K
Relative Volume:
0.58
Capitalizzazione di mercato:
$326.25M
Reddito:
$157.75M
Utile/perdita netta:
$-29.73M
Rapporto P/E:
-10.37
EPS:
-1.16
Flusso di cassa netto:
$-21.00M
1 W Prestazione:
-5.12%
1M Prestazione:
-6.66%
6M Prestazione:
-31.18%
1 anno Prestazione:
-60.37%
Intervallo 1D:
Value
$12.02
$12.54
Intervallo di 1 settimana:
Value
$11.67
$13.00
Portata 52W:
Value
$8.04
$45.00

Arcturus Therapeutics Holdings Inc Stock (ARCT) Company Profile

Name
Nome
Arcturus Therapeutics Holdings Inc
Name
Telefono
(858) 900-2660
Name
Indirizzo
10628 SCIENCE CENTER DRIVE, SAN DIEGO, CA
Name
Dipendente
176
Name
Cinguettio
@ArcturusRx
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
ARCT's Discussions on Twitter

Confronta ARCT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ARCT
Arcturus Therapeutics Holdings Inc
12.03 325.18M 157.75M -29.73M -21.00M -1.16
Biotechnology icon
ONC
Beigene Ltd Adr
238.19 25.23B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.67 113.16B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.26 40.65M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
603.09 64.41B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
75.58 6.18B 0 -153.72M -103.81M -2.00

Arcturus Therapeutics Holdings Inc Stock (ARCT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-01-28 Iniziato BTIG Research Buy
2024-08-12 Iniziato Leerink Partners Outperform
2023-12-13 Iniziato Canaccord Genuity Buy
2023-07-24 Iniziato William Blair Outperform
2023-05-11 Aggiornamento H.C. Wainwright Neutral → Buy
2022-11-14 Ripresa Wells Fargo Overweight
2022-11-10 Downgrade Robert W. Baird Neutral → Underperform
2022-11-03 Aggiornamento Citigroup Neutral → Buy
2022-11-02 Aggiornamento Barclays Underweight → Equal Weight
2022-08-10 Downgrade Raymond James Mkt Perform → Underperform
2022-07-19 Ripresa Cantor Fitzgerald Overweight
2022-05-11 Aggiornamento Robert W. Baird Underperform → Neutral
2022-04-21 Downgrade Citigroup Buy → Neutral
2022-01-31 Aggiornamento Raymond James Underperform → Mkt Perform
2021-08-12 Downgrade Raymond James Mkt Perform → Underperform
2021-08-11 Downgrade Goldman Neutral → Sell
2021-08-10 Downgrade Robert W. Baird Neutral → Underperform
2021-07-02 Iniziato Cantor Fitzgerald Overweight
2021-06-25 Ripresa Goldman Neutral
2021-06-21 Downgrade Barclays Equal Weight → Underweight
2021-06-04 Ripresa Robert W. Baird Neutral
2021-02-17 Downgrade B. Riley Securities Neutral → Sell
2021-01-19 Downgrade B. Riley Securities Buy → Neutral
2021-01-15 Downgrade B. Riley Securities Buy → Neutral
2021-01-07 Iniziato Wells Fargo Overweight
2020-12-29 Downgrade Barclays Overweight → Equal Weight
2020-12-29 Downgrade H.C. Wainwright Buy → Neutral
2020-12-29 Downgrade Raymond James Outperform → Mkt Perform
2020-12-29 Downgrade Robert W. Baird Outperform → Neutral
2020-12-23 Downgrade ROTH Capital Buy → Sell
2020-12-08 Reiterato B. Riley Securities Buy
2020-12-07 Reiterato B. Riley Securities Buy
2020-10-26 Iniziato Barclays Overweight
2020-10-06 Iniziato Citigroup Buy
2020-08-26 Iniziato Piper Sandler Overweight
2020-07-30 Ripresa ROTH Capital Buy
2020-07-16 Iniziato Raymond James Outperform
2020-07-13 Iniziato B. Riley FBR Buy
2020-06-09 Downgrade WBB Securities Buy → Hold
2020-02-11 Iniziato Robert W. Baird Outperform
2020-02-07 Iniziato Guggenheim Buy
2020-02-06 Iniziato Guggenheim Buy
2019-04-05 Iniziato H.C. Wainwright Buy
2018-09-20 Aggiornamento WBB Securities Buy → Strong Buy
2018-01-22 Iniziato Chardan Capital Markets Buy
Mostra tutto

Arcturus Therapeutics Holdings Inc Borsa (ARCT) Ultime notizie

pulisher
May 24, 2025

Arcturus Therapeutics’ SWOT analysis: mRNA innovator’s stock faces pivotal year - Investing.com

May 24, 2025
pulisher
May 24, 2025

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Given Average Recommendation of “Buy” by Brokerages - Defense World

May 24, 2025
pulisher
May 24, 2025

Wall Street Zen Upgrades Arcturus Therapeutics (NASDAQ:ARCT) to “Hold” - Defense World

May 24, 2025
pulisher
May 22, 2025

Northern Trust Corp Has $4.35 Million Stock Position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

May 22, 2025
pulisher
May 18, 2025

Trend Tracker for (ARCT) - news.stocktradersdaily.com

May 18, 2025
pulisher
May 17, 2025

Wells Fargo & Company Cuts Arcturus Therapeutics (NASDAQ:ARCT) Price Target to $45.00 - Defense World

May 17, 2025
pulisher
May 16, 2025

Arcturus signals extended cash runway into 2028 with strategic shift toward CF and OTC mRNA therapeutics - MSN

May 16, 2025
pulisher
May 16, 2025

FY2025 EPS Estimates for ARCT Raised by Cantor Fitzgerald - The AM Reporter

May 16, 2025
pulisher
May 16, 2025

Leerink Partnrs Analysts Raise Earnings Estimates for ARCT - Defense World

May 16, 2025
pulisher
May 16, 2025

Price T Rowe Associates Inc. MD Increases Stock Position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

May 16, 2025
pulisher
May 16, 2025

William Blair Brokers Boost Earnings Estimates for ARCT - Defense World

May 16, 2025
pulisher
May 15, 2025

Wall Street Analysts Believe Arcturus Therapeutics (ARCT) Could Rally 503.6%: Here's is How to Trade - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

Canaccord Genuity Group Issues Pessimistic Forecast for Arcturus Therapeutics (NASDAQ:ARCT) Stock Price - Defense World

May 15, 2025
pulisher
May 14, 2025

Arcturus Therapeutics (ARCT): Wells Fargo Maintains Rating, Lowe - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q1 2025 Earnings Call Transcript - Insider Monkey

May 14, 2025
pulisher
May 14, 2025

Wells Fargo Adjusts Price Target for Arcturus Therapeutics (ARCT - GuruFocus

May 14, 2025
pulisher
May 13, 2025

Arcturus Therapeutics (ARCT) Set for Potential Upside with Citi's Confidence | ARCT Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Arcturus Therapeutics Holdings Inc earnings missed by $4.11, revenue fell short of estimates - Investing.com Nigeria

May 13, 2025
pulisher
May 13, 2025

Canaccord Genuity Maintains Buy Rating on Arcturus Therapeutics (ARCT) | ARCT Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Demystifying Arcturus Therapeutics: Insights From 7 Analyst Reviews - Benzinga

May 13, 2025
pulisher
May 13, 2025

Arcturus Therapeutics (ARCT) Price Target Revised by Canaccord | - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Arcturus Therapeutics Holdings Inc (ARCT) Q1 2025 Earnings: EPS - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Arcturus Therapeutics Holdings Inc (ARCT) Q1 2025 Earnings Call Highlights: Strategic Focus and ... - Yahoo Finance

May 13, 2025
pulisher
May 13, 2025

Arcturus Therapeutics Holdings Inc (ARCT) Q1 2025 Earnings Call - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Arcturus Therapeutics Reports Q1 2025 Financial Update - TipRanks

May 13, 2025
pulisher
May 12, 2025

Arcturus Therapeutics (ARCT) Sees Strong Progress with Pipeline Programs - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Earnings call transcript: Arcturus Therapeutics Q1 2025 sees revenue drop, stock rises - Investing.com

May 12, 2025
pulisher
May 12, 2025

Arcturus Therapeutics (ARCT) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 12, 2025
pulisher
May 12, 2025

Arcturus Therapeutics Holdings Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025
pulisher
May 12, 2025

Arcturus Therapeutics (ARCT) Surpasses Q1 Revenue Expectations | - GuruFocus

May 12, 2025
pulisher
May 12, 2025

ARCTURUS THERAPEUTICS Earnings Results: $ARCT Reports Quarterly Earnings - Nasdaq

May 12, 2025
pulisher
May 12, 2025

Arcturus Therapeutics stock jumps 7% despite Q1 loss By Investing.com - Investing.com Canada

May 12, 2025
pulisher
May 12, 2025

Arcturus Therapeutics stock jumps 7% despite Q1 loss - Investing.com Australia

May 12, 2025
pulisher
May 12, 2025

Arcturus Therapeutics: Q1 Earnings Snapshot - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

Arcturus Therapeutics Announces First Quarter 2025 Financial Update and Pipeline Progress - Business Wire

May 12, 2025
pulisher
May 10, 2025

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Shares Sold by Dimensional Fund Advisors LP - Defense World

May 10, 2025
pulisher
May 10, 2025

Arcturus Therapeutics (ARCT) to Release Quarterly Earnings on Monday - Defense World

May 10, 2025
pulisher
May 09, 2025

Earnings To Watch: Arcturus Therapeutics Holdings Inc (ARCT) Reports Q1 2025 Result - Yahoo Finance

May 09, 2025
pulisher
May 08, 2025

MetLife Investment Management LLC Has $283,000 Holdings in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

May 08, 2025
pulisher
May 06, 2025

Barclays PLC Sells 7,333 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

May 06, 2025
pulisher
May 05, 2025

Earnings Preview: Arcturus Therapeutics (ARCT) Q1 Earnings Expected to Decline - Yahoo Finance

May 05, 2025
pulisher
May 04, 2025

Arcturus Therapeutics Holdings Inc.'s (NASDAQ:ARCT) Price Is Right But Growth Is Lacking After Shares Rocket 41% - simplywall.st

May 04, 2025
pulisher
May 02, 2025

Brokerages Set Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) PT at $59.20 - Defense World

May 02, 2025
pulisher
Apr 30, 2025

Sumitomo Mitsui Trust Group, Inc. Reduces Stake in Arcturus Ther - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

Legal & General Group Plc Has $410,000 Position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

Apr 30, 2025
pulisher
Apr 30, 2025

LPL Financial LLC Has $195,000 Stake in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

Apr 30, 2025
pulisher
Apr 29, 2025

Wells Fargo & Company MN Acquires 7,785 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

Apr 29, 2025

Arcturus Therapeutics Holdings Inc Azioni (ARCT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$1.18
price up icon 3.48%
$31.00
price down icon 1.26%
$591.19
price up icon 0.64%
$289.96
price up icon 1.93%
$4.22
price down icon 0.71%
$75.88
price up icon 1.88%
Capitalizzazione:     |  Volume (24 ore):